Background: Background: Ullrich congenital muscular dystrophy (UCMD) is a unique congenital disorder characterized clinically by generalized muscle weakness, contractures of the proximal joints and hyperextensibility of the distal joints and begins from birth or early infancy. Materials and Methods:
Introduction
Ullrich disease or Ullrich congenital muscular dystrophy (UCMD) was first described in 1930 as an unusual form of congenital muscular dystrophy in two boys and called as congenital hypotonic-sclerotic muscular dystrophy. [1] The predominant clinical manifestations include generalized muscle weakness and wasting, prominent contractures of the proximal joints and hyperextensibility of the distal joints from infancy and a progressive course. The other characteristic feature is prominent calcanei and normal intelligence. Complete deficiency or reduction of Collagen VI protein has been demonstrated in skeletal muscle in Ullrich CMD. [2] [3] [4] [5] [6] Molecular genetically frame shift mutations in the gene encoding Collagen VI alpha 2 (COL6A2) has been described. [2, 3, 7, 8] We report nine children with UCMD with deficiency of Collagen VI A1 protein confirmed by immunohistochemistry.
Original Article
clinical, histopathological and immunohistochemical study was undertaken. Clinical data including perinatal complications and problems, age of onset and progression of weakness, wasting and contractures in all patients. A detailed pedigree diagram was created for all. Written informed consent was obtained from the parents for their children to undergo investigations and for publication of their photographs. Muscle biopsy done on seven cases was subjected to a battery of enzyme (SDH, NADH-Tr, ATPase pH 9.4,4.6, acid phosphatsase) and nonenzyme (HE,MGT,PAS) stains. Immunohistochemistry to monoclonal antibodies against dystrophin (1,2,3), sarcoglycans (α,β,γ,δ), α2 laminin, β-dystroglycan (NCL, UK) and Collagen VI A1 (Santa Cruz, Europe) as primary and LSAB + (DAKO) as secondary was carried out.
Results
Over the last two years (2005 to 2008), nine children from seven families with classical phenotype of UCMD were studied. There were eight boys and one girl child and all had symptoms from birth. Consanguinity was present in five families. The mean age at diagnosis was 4.5 years (range 1-8). All were observed to have contractures at birth. Grossly, delayed motor milestones were present and none attained ability to stand or walk independently. All had attained neck control and were able to sit with support. The details of the clinical picture and laboratory findings in each patient are represented in Table 1 . Higher mental functions were normal and appropriate for the age. The patients had failure to thrive and the weight was below the 25 th percentile. Abnormal facial characteristics, bifacial weakness, thin habitus with generalized muscle wasting were seen in all patients. Classical protuberant calcanei were noted in all. Distal wasting appeared more prominent than proximal with severe weakness, proximal more tan distal including truncal muscles. Deep tendon reflexes were absent. Contractures were present at the shoulders, elbows, hips and knees. Hyperlaxity was evident at the wrists, fingers, ankles and toes. Seven had rigidity of the spine with moderate to severe kypho-scoliosis [ Figure 1a -g]. The scoliosis was progressive. Two patients had early respiratory failure. All patients had the typical velvety palms and soles and almost total absence of the major palmar and plantar creases. Instead there were fine lines with a mesh-like appearance [ Figure 2a , Figure 2b ]. Creatine kinase level was normal in seven and minimally elevated in one. ECG and 2D echocardiogram were normal in all. EMG showed myopathic process. Brain magnetic resonance imaging (MRI) done in three patients was normal. Muscle biopsy revealed dystrophic features with mild to moderate numbers of atrophic fibers with pyknotic nuclei in all. In addition, a few lobulated fibers and Type 1 fiber predominance were noted in three cases (Cases 4, 8 and 9). Immunostaining to Collagen VI A1 (COL 6A1) was totally absent in six of the seven cases while sarcolemmal-specific deficiency was seen in one (Case 1). There was no deficiency of dystrophin, sarcoglycans, merosin, dysferlin, or beta dystroglycan [ Figure 3a -h].
Discussion
The present study reveals nine children with classical phenotype of UCMD, confirmed immunohistochemically by deficiency of COL 6A1. Typically, all shared a similar clinical history with onset in infancy, characteristic facial appearance, proximal contractures, distal hyperextensibility of joints, protuberant calcanei, delayed motor milestones, generalized muscle wasting with weakness and normal mental functions and dystrophic features on muscle biopsy. Collagen VI, a ubiquitous extracellular matrix protein, forms a microfibrillar network in association with basement the interstitium. [9, 10] It is reported that patients with UCMD have soft velvety palms and soles. [11] All our patients had this classical soft and velvety skin on the palms and soles. Interestingly, the major proximal, middle and distal creases were absent and there were mesh-like fine creases on the palms and soles. Hitherto, this finding has not been described in the reports in English literature. Collagen provides a framework that gives the tissues their form and strength. [12] It has been demonstrated that alteration in the control mechanisms can change the balance between synthesis and degradation of collagen, thus leading to either excessive deposition or depletion of collagen. Several collagen disorders result from defects in the formation of cross-links. [13] It is possible that abnormalities in the packing of collagen molecules into a fiber or in the interaction of collagen fibers with other extracellular components of connective tissue may be the cause for the significantly reduced dermal creases in our patients.
Morphologically, muscle biopsy revealed dystrophic features in all. Immunostaining to Col 6 A1 showed total absence of the protein in five patients. This finding was similar to those reported previously. [5, 8, 11] In one patient there was sarcolemmal-specific deficiency (SCCD). This finding has been reported by Kawahara et al., wherein a heterozygous Col 6A1 Glycine substitution that influences cell attachment in fibroblasts causes SCCD. [14] It is known that in some patients with the UCMD phenotype, the role of Collagen VI molecules has been excluded, suggesting genetic heterogeneity for this disorder. [7] Hence, in our cases the clinical and immunohistochemical diagnosis is UCMD with a pending genetic confirmation. Thus, final diagnosis membrane around muscle cells. Mutations in gene encoding Col 6 leading to total / partial loss of Col 6 results in loss of integrity between the basal lamina and requires molecular genetic testing, which is currently available only at a few medical centers in the world.
Treatment for UCMD is largely supportive and depends on the intensity of the severity of symptoms and age at onset. Children with severe UCMD require early mobilization in a standing frame to achieve upright posture and protect against scoliosis and contractures. Regular stretching and splinting are useful. Scoliosis surgery may be required later in life. There are presently no definite / specific therapeutic options but supportive treatment is known to dramatically improve the longevity and quality of life. [11] A turning point in basic research on Collagen VI myopathies is the discovery of mitochondrial dysfunction seen in Col6a1 null mice. Treatment of Col6a1(-/-) mice with cyclosporine A rescued the mitochondrial dysfunction and decreased apotosis. [15] Similar mitochondrial defects were revealed in cultures of UCMD patients and myoblasts from patients affected with UCMD displayed functional and ultrastuctural mitochondrial alterations. [16] Closely following this an open pilot trial with cyclosporine A in five patients with UCMD was reported. Before treatment all patients displayed mitochondrial dysfunction and increased frequency of apotosis, as determined in muscle biopsies. Both these pathologic signs were largely normalized after one month of oral cyclosporine A administration, which also increased muscle regeneration. [17] These findings demonstrate that drugs acting on the pathogenic mechanism represent an important proof for potential therapy in genetic disorders like UCMD.
For families where the muscle biopsy of the proband shows absence of Collagen VI immunolabeling, examination of chorionic villus biopsy along with linkage analysis, offers a potential route for prenatal diagnosis even if the causative mutation is not known in the family. [11] Thus, identifying this form of CMD is of importance to the families if there is an opportunity for prenatal diagnosis.
